your path

Ready to take the next step?

Fill out this simple form and we’ll call you right back.
Click here
Click here

GMP-CERTIFIED PHARMACEUTICAL MANUFACTURING

 

100+

International controlled substance shipments under ANVISA & US DEA import permits.

30+

SKUs of pharmaceutical APIs and pharma-grade nutraceuticals available for export.

 

We founded mPath to improve human health for those suffering unnecessarily. And with our sister company, Seven10 Pharmaceuticals, we’re changing the way plant-based medicines are manufactured and utilized to bring health, happiness and natural relief to patients from all over the world.

Our production facilities already ship botanical medicines to South America in compliance with product registration and import permit requirements, and are already available for legal import into the US.

RESEARCH AND INTELLECTUAL PROPERTY

The adaptability of our production facility allows us to pursue other promising indications for Ibogaine treatment. Recent advancements with an Ibogaine derivative, for instance, have produced a 90-100% amelioration or elimination of all motor and non-motor Parkinsonian symptoms, delivering a tremendous increase in Quality of Life.

With our GMP-certification, our goal is to lead in researching similar applications toward the development of novel IP for new medications by combining Ibogaine with other excipients. A second compound for Parkinsons tops the list, followed by numerous other disorders identified as highly promising, such as Multiple Sclerosis, drug and alcohol dependency, depression and anxiety.

GMP-CERTIFIED PHARMACEUTICAL MANUFACTURING

100+

International controlled substance shipments under ANVISA & US DEA import permits.

30+

SKUs of pharmaceutical APIs and pharma-grade nutraceuticals available for export.

We founded mPath to improve human health for those suffering unnecessarily. And with our sister company, Seven10 Pharmaceuticals, we’re changing the way plant-based medicines are manufactured and utilized to bring health, happiness and natural relief to patients from all over the world.

Our production facilities already ship botanical medicines to South America in compliance with product registration and import permit requirements, and are already available for legal import into the US.

RESEARCH AND INTELLECTUAL PROPERTY

The adaptability of our production facility allows us to pursue other promising indications for Ibogaine treatment. Recent advancements with an Ibogaine derivative, for instance, have produced a 90-100% amelioration or elimination of all motor and non-motor Parkinsonian symptoms, delivering a tremendous increase in Quality of Life.

With our GMP-certification, our goal is to lead in researching similar applications toward the development of novel IP for new medications by combining Ibogaine with other excipients. A second compound for Parkinsons tops the list, followed by numerous other disorders identified as highly promising, such as Multiple Sclerosis, drug and alcohol dependency, depression and anxiety.